Now showing items 631-650 of 1231

      Neuraminidase inhibitors--the story behind the Cochrane review [1]
      Neuropsychopharmacology and molecular pharmacology of the cannabinoid system in the learned helpless model of depression [1]
      New Vistas in Zinc Finger Biochemistry: Examining the Metal-Mediated DNA Recognition of the Neural Zinc Finger Factor/Myelin Transcription Factor Family of Non-Classical Zinc Finger Proteins and Creating Catalytic Moieties from Zinc Finger Scaffolds [1]
      Newsletter for the Maryland Academy of Preceptors [11]
      Niacin: Summary Report [1]
      Niacinamide: Summary Report [1]
      Nicotinamide adenine dinucleotide: Summary Report [1]
      Nifedipine: Summary Report [1]
      No correction, no retraction, no apology, no comment: paroxetine trial reanalysis raises questions about institutional responsibility [1]
      Noel E. Foss [Portrait] [1]
      Non-covalent Interactions in Peptide Hydrogels: A Mechanism for Mechanical and Structural Control [1]
      Noninferiority Trials [letter to the editor] [1]
      Nontraditional Doctor of Pharmacy (Pharm.D.), 1994-1995 [1]
      North American regulatory agencies can and should make clinical trial data publicly available [1]
      Novel Approach to an Assessment Committee [1]
      Novel Cholinergics for Treatment of Central Nervous System Disorders [1]
      Novel Extracellular Signal-Regulated Kinase (ERK) Targeted Inhibitors Effects on Apoptotic Signaling: A Potential Cancer Therapy [1]
      Novel human Constitutive Androstane Receptor Activators and their Effects on Hepatic Energy Homeostasis [1]
      Novel Lipid A Structures for Adjuvant Discovery and Development [1]
      Novel WNT/beta-catenin Signaling Pathway Inhibitors for the Treatment of Metabolic Disorders [1]